Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Mills

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Clinical Chemistry|March 30, 2017
Precision Medicine-Right Treatment, Right Patient, Right Time, Wrong Approach?John R Mills
Clinical Chemistry|February 29, 2020
Commentary on An Elderly Man with DementiaJohn R Mills
Clinical Chemistry|February 6, 2015
To monitor dabigatran or not: a matter of patient safetyHemamalini Ketha, John R Mills
Cancer Detection and Prevention|July 10, 2009
Epidemiology of primary brain tumors in the Middle Eastern population in California, USA 2001-2005Kiumarss Nasseri, John R Mills
Clinical Chemistry|February 27, 2020
The Now and Beyond of Tumor Mutational Burden as a Predictor of Response to Immune Checkpoint InhibitorsVijayalakshmi Nandakumar, John R Mills
Current Opinion in Gastroenterology|January 20, 2016
Contemporary celiac disease diagnosis: is a biopsy avoidable?John R Mills, Joseph A Murray
The Journal of Applied Laboratory Medicine|February 27, 2021
Identification of Friend or Foe: The Laboratory Challenge of Differentiating M-Proteins from Monoclonal Antibody TherapiesJohn R Mills, David L Murray
Cell Cycle (Georgetown, Tex.)|December 22, 2011
Inhibiting mitochondrial-dependent proteolysis of Mcl-1 promotes resistance to DNA damageJohn R Mills, Abba Malina, Jerry Pelletier
Handbook of Clinical Neurology|March 17, 2024
Evolution of methods to detect paraneoplastic antibodiesPatrick Waters, John R Mills, Hannah Fox
Cold Spring Harbor Perspectives in Biology|April 5, 2012
Emerging therapeutics targeting mRNA translationAbba Malina, John R Mills, Jerry Pelletier
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Clinical Chemistry|March 30, 2017
Precision Medicine-Right Treatment, Right Patient, Right Time, Wrong Approach?John R Mills
Clinical Chemistry|February 29, 2020
Commentary on An Elderly Man with DementiaJohn R Mills
Clinical Chemistry|February 6, 2015
To monitor dabigatran or not: a matter of patient safetyHemamalini Ketha, John R Mills
Cancer Detection and Prevention|July 10, 2009
Epidemiology of primary brain tumors in the Middle Eastern population in California, USA 2001-2005Kiumarss Nasseri, John R Mills
Clinical Chemistry|February 27, 2020
The Now and Beyond of Tumor Mutational Burden as a Predictor of Response to Immune Checkpoint InhibitorsVijayalakshmi Nandakumar, John R Mills
Current Opinion in Gastroenterology|January 20, 2016
Contemporary celiac disease diagnosis: is a biopsy avoidable?John R Mills, Joseph A Murray
The Journal of Applied Laboratory Medicine|February 27, 2021
Identification of Friend or Foe: The Laboratory Challenge of Differentiating M-Proteins from Monoclonal Antibody TherapiesJohn R Mills, David L Murray
Cell Cycle (Georgetown, Tex.)|December 22, 2011
Inhibiting mitochondrial-dependent proteolysis of Mcl-1 promotes resistance to DNA damageJohn R Mills, Abba Malina, Jerry Pelletier
Handbook of Clinical Neurology|March 17, 2024
Evolution of methods to detect paraneoplastic antibodiesPatrick Waters, John R Mills, Hannah Fox
Cold Spring Harbor Perspectives in Biology|April 5, 2012
Emerging therapeutics targeting mRNA translationAbba Malina, John R Mills, Jerry Pelletier
Pageof 12